Regeneron v Kymab UK Supreme Court decision - Bristows

This article was first published in AIPPI Japanese Journal, April 2021.

Partner Robert Burrows and associate Ben Millson review the Supreme Court’s decision in Regeneron v Kymab.

Read the full Japanese article here.

Read the full English version here.

Ben Millson

Related Articles

A role for the UK courts in a new world of UPC litigation?

Questions remain over fate of Retained EU law

Court of Appeal examines clause 6.1 of the ETSI IPR Policy

The Unified Patent Court: What Pharma Companies Need to Know

Spin-out companies – what do you need to consider

Synthetic brain, public domain?

View more